Abbott Laboratories (ABT)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $187.95B
Last updated: Nov 17, 2026 at 11:05 AM ET
Abbott Laboratories (ABT) P/E Ratio & Valuation History
Abbott Laboratories (ABT) trades at 20.0x trailing earnings and 3.9x sales. Its P/E of 20.0x is below its 5-year median of 23.7x. Its forward P/E is 18.3x. The median P/E across 10 similar companies is 19.0x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 9.3% higher over the next year. Its free cash flow yield is 3.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 20.0x |
| Forward P/E | 18.3x |
| Price to sales | 3.9x |
| Price to book | 3.7x |
| EV/EBITDA | 19.1x |
| Price to FCF | 27.6x |
| EV/FCF | 31.6x |
| PEG | 1.6 |
| FCF yield | 3.6% |
Historical Medians
Against its 10-year medians, its P/E is 17.7% below 24.3x, its P/S is 15.2% below 4.6x and its P/B is 21.3% below 4.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 20.0x | 23.7x | 24.3x |
| P/S | 3.9x | 4.6x | 4.6x |
| P/B | 3.7x | 4.8x | 4.7x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 17.5x in 2016 to 30.0x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $125.29 | 24.3x | 4.9x | 4.2x |
| 2024 | $113.11 | 24.2x | 4.7x | 4.1x |
| 2023 | $110.07 | 24.8x | 4.8x | 5.0x |
| 2022 | $109.79 | 20.6x | 4.4x | 5.2x |
| 2021 | $140.74 | 27.0x | 5.8x | 7.0x |
| 2020 | $109.49 | 30.0x | 5.6x | 6.0x |
| 2019 | $86.86 | 26.8x | 4.8x | 5.0x |
| 2018 | $72.33 | 25.1x | 4.2x | 4.2x |
| 2017 | $57.07 | 22.8x | 3.6x | 3.2x |
| 2016 | $38.41 | 17.5x | 2.7x | 2.8x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ABT
What is ABT's forward P/E ratio?
Abbott Laboratories has a forward P/E ratio of 18.3x.
Is ABT stock overvalued?
GNG's valuation label for ABT is Undervalued. Its P/E of 20.0x compares with a median of 19.0x across 10 similar companies.
What is ABT's price to sales ratio?
Abbott Laboratories has a price to sales ratio of 3.9x.
What is Abbott Laboratories's average P/E ratio over 5 years?
Abbott Laboratories's median P/E over the last 5 years is 23.7x, from 60 month-end values through Oct 2026.
What is ABT's PEG ratio?
Abbott Laboratories has a PEG ratio of 1.6.
ABT pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts